BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 18091698)

  • 1. Markers of inflammation and prevalence of vascular disease in patients with metabolic syndrome.
    Novo G; Corrado E; Muratori I; Tantillo R; Bellia A; Galluzzo A; Vitale G; Novo S
    Int Angiol; 2007 Dec; 26(4):312-7. PubMed ID: 18091698
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The predictive role of C-reactive protein in patients with hypertension and subclinical atherosclerosis.
    Rizzo M; Corrado E; Coppola G; Muratori I; Mezzani A; Novo G; Novo S
    Intern Med J; 2009 Aug; 39(8):539-45. PubMed ID: 19323703
    [TBL] [Abstract][Full Text] [Related]  

  • 3. C-reactive protein is a strong independent predictor of death in type 2 diabetes: association with multiple facets of the metabolic syndrome.
    Linnemann B; Voigt W; Nobel W; Janka HU
    Exp Clin Endocrinol Diabetes; 2006 Mar; 114(3):127-34. PubMed ID: 16636979
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased lipoprotein(a) in metabolic syndrome: is it a contributing factor to premature atherosclerosis?
    Bozbaş H; Yildirir A; Pirat B; Eroğlu S; Korkmaz ME; Atar I; Ulus T; Aydinalp A; Ozin B; Müderrisoğlu H
    Anadolu Kardiyol Derg; 2008 Apr; 8(2):111-5. PubMed ID: 18400630
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Older age and markers of inflammation are strong predictors of clinical events in women with asymptomatic carotid lesions.
    Corrado E; Rizzo M; Muratori I; Coppola G; Novo S
    Menopause; 2008; 15(2):240-7. PubMed ID: 17917609
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High serum high-sensitivity C-reactive protein concentrations are associated with relative cardiac sympathetic overactivity during the early morning period in type 2 diabetic patients with metabolic syndrome.
    Aso Y; Wakabayashi S; Nakano T; Yamamoto R; Takebayashi K; Inukai T
    Metabolism; 2006 Aug; 55(8):1014-21. PubMed ID: 16839835
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diabetes exacerbates angiographic coronary lesion progression in subjects with metabolic syndrome independent of CRP levels.
    Liang KW; Lee WJ; Lee WL; Chen YT; Ting CT; Sheu WH
    Clin Chim Acta; 2008 Feb; 388(1-2):41-5. PubMed ID: 17967444
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The presence of metabolic syndrome is independently associated with elevated serum CD40 ligand and disease severity in patients with symptomatic coronary artery disease.
    Lee WL; Lee WJ; Chen YT; Liu TJ; Liang KW; Ting CT; Huey-Herng Sheu W
    Metabolism; 2006 Aug; 55(8):1029-34. PubMed ID: 16839837
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low-grade inflammation can partly explain the association between the metabolic syndrome and either coronary artery disease or severity of peripheral arterial disease: the CODAM study.
    Jacobs M; van Greevenbroek MM; van der Kallen CJ; Ferreira I; Blaak EE; Feskens EJ; Jansen EH; Schalkwijk CG; Stehouwer CD
    Eur J Clin Invest; 2009 Jun; 39(6):437-44. PubMed ID: 19397692
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence and correlates of metabolic syndrome (MS) in older adults.
    Cankurtaran M; Halil M; Yavuz BB; Dagli N; Oyan B; Ariogul S
    Arch Gerontol Geriatr; 2006; 42(1):35-45. PubMed ID: 16046242
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Carotid and peripheral atherosclerosis in patients who underwent primary percutaneous coronary intervention and outcome associated with multifocal atherosclerosis.
    Romano G; Corrado E; Muratori I; Novo G; Andolina G; Cospite V; Evola S; Ciaramitaro GF; Di Vincenzo A; Farinella M; Rotolo A; Assennato P; Hoffmann E; Novo S
    Int Angiol; 2006 Dec; 25(4):389-94. PubMed ID: 17164746
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolic syndrome, C-reactive protein, and prognosis in patients with established coronary artery disease.
    Aguilar D; Fisher MR; O'Connor CM; Dunne MW; Muhlestein JB; Yao L; Gupta S; Benner RJ; Cook TD; Edwards D; Pfeffer MA;
    Am Heart J; 2006 Aug; 152(2):298-304. PubMed ID: 16875914
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Associations of serum uric acid with markers of inflammation, metabolic syndrome, and subclinical coronary atherosclerosis.
    Coutinho Tde A; Turner ST; Peyser PA; Bielak LF; Sheedy PF; Kullo IJ
    Am J Hypertens; 2007 Jan; 20(1):83-9. PubMed ID: 17198917
    [TBL] [Abstract][Full Text] [Related]  

  • 14. "Poor man's risk factor": correlation between high sensitivity C-reactive protein and socio-economic class in patients of acute coronary syndrome.
    Sethi R; Puri A; Makhija A; Singhal A; Ahuja A; Mukerjee S; Dwivedi SK; Narain VS; Saran RK; Puri VK
    Indian Heart J; 2008; 60(3):205-9. PubMed ID: 19240308
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The prevalence of peripheral arterial disease in high risk subjects and coronary or cerebrovascular patients.
    Poredos P; Jug B
    Angiology; 2007; 58(3):309-15. PubMed ID: 17626985
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum uric acid levels and risk for vascular diseases in patients with metabolic syndrome.
    Hjortnaes J; Algra A; Olijhoek J; Huisman M; Jacobs J; van der Graaf Y; Visseren F
    J Rheumatol; 2007 Sep; 34(9):1882-7. PubMed ID: 17696269
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma pyridoxal 5'-phosphate and high-sensitivity C-reactive protein are independently associated with an increased risk of coronary artery disease.
    Cheng CH; Lin PT; Liaw YP; Ho CC; Tsai TP; Chou MC; Huang YC
    Nutrition; 2008 Mar; 24(3):239-44. PubMed ID: 18312786
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolic syndrome is not associated with markers of subclinical atherosclerosis, serum adiponectin and endogenous androgen concentrations in Japanese men with Type 2 diabetes.
    Fukui M; Ose H; Kitagawa Y; Kamiuchi K; Nakayama I; Ohta M; Obayashi H; Yamasaki M; Hasegawa G; Yoshikawa T; Nakamura N
    Diabet Med; 2007 Aug; 24(8):864-71. PubMed ID: 17593243
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Correlation of high-sensitivity CRP concentration with the extent of coronary atherosclerosis in men with symptoms of ischemic heart disease].
    Piechota W; Piechota W
    Pol Merkur Lekarski; 2005 May; 18(107):511-5. PubMed ID: 16161944
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Level of high-sensitivity C-reactive protein in Saudi patients with chronic stable coronary artery disease.
    Habib SS
    J Ayub Med Coll Abbottabad; 2008; 20(2):3-6. PubMed ID: 19385446
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.